PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 23484005 ↗2013Reported benefit

A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation.

MouseChemical/toxinC57BL/6JFemalen = n = 6 to 7 mice per group for lavage differential counts; n…Oropharyngeal aspiration (inhalation)100 ng RvD1 or 100 ng 17R-RvD1 in 40 microlitres salinePre-treatment model: on day 0 and 1 hour before the first smoke exposure on day…

Model: Acute cigarette smoke-induced lung inflammation, dilute mainstream smoke for 1 hour twice daily for 3 days at nominal 450 mg/m3 total suspended particulate; the resolution model used 2 hours per day on days 1 to 3

RvD1 given concurrently with cigarette smoke significantly reduced lavage neutrophils, total protein, KC, MIP-2, interleukin-1beta, interleukin-6, prostaglandin E2 and COX-2, and increased interleukin-10, while promoting M2 macrophage polarisation and neutrophil efferocytosis. A single dose of 17R-…

Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.